The unidentified disease has infected at least 300 people in the Democratic Republic of the Congo since November 10, causing ...

Fostamatinib was approved in 2018 to treat adults with chronic immune thrombocytopenia (ITP) who had an insufficient response ...

As family members gather at each other's houses this holiday season, illness might tag along. Here's what you need to know ...

A nasal spray formulation of bumetanide has been shown to be safe and effective in a new study and could ultimately prevent ...

More people living in rural areas of the United States are dying from heart attacks, strokes and other cardiovascular ...

New research published in the journal Proceedings of the National Academy of Sciences sheds light on the pathways that drive organ damage and death in severe COVID-19 and helps explain why survivors ...

Supported by private donations administered through UHN Foundation, as well as research grants from agencies such as the ...

COVID-19 patients face an elevated risk of MACE, including heart attack, stroke and all-cause mortality, that persists for more than two years after infection. The study found that the risk of MACE ...

By slicing and dicing a dataset from 277 million patients at 1,591 hospitals, Epic publishes findings more quickly than ...

Janette Nesheiwat, a family medicine doctor who runs a chain of urgent care clinics, is President-elect Donald Trump ’s pick ...

Routine screening to detect risk factors for heart disease dropped sharply during the COVID-19 pandemic in England, and some key measurements, such as blood pressure readings, may still lag behind pre ...